Compare MOB & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MOB | HYFT |
|---|---|---|
| Founded | 2008 | 1983 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.0M | 84.0M |
| IPO Year | 2022 | 2017 |
| Metric | MOB | HYFT |
|---|---|---|
| Price | $6.13 | $1.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | 590.2K | ★ 666.8K |
| Earning Date | 08-12-2025 | 12-15-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,826,361.00 | ★ $19,019,110.00 |
| Revenue This Year | $94.62 | N/A |
| Revenue Next Year | N/A | $51.71 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 49.46 |
| 52 Week Low | $5.33 | $0.27 |
| 52 Week High | $9.78 | $3.25 |
| Indicator | MOB | HYFT |
|---|---|---|
| Relative Strength Index (RSI) | 40.94 | 32.72 |
| Support Level | $6.10 | $1.85 |
| Resistance Level | $7.34 | $2.39 |
| Average True Range (ATR) | 1.21 | 0.20 |
| MACD | -0.26 | -0.09 |
| Stochastic Oscillator | 16.24 | 1.03 |
Mobilicom Ltd is a provider of cybersecurity and smart solutions for drones, robotics & autonomous platforms. As a high-tech company, it designs, develops, and delivers smart solutions targeting global drone, robotics, and autonomous system manufacturers. Its products include OS3 Platform Software, ICE Cybersecurity Software, MCU Mesh Networking, SkyHopper Datalinks, Mobile Ground Control Stations and System Engineering Services.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.